FoRx Therapeutics discloses its Board with Dr Colin Goddard as Executive Chairman and announces €10m seed financing led by M Ventures, Novartis Venture Fund and Omega Funds

– SWITZERLAND, Basel –  FoRx Therapeutics AG, the biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress (DRS) pathways, today announced the closing of a EUR 10 million seed financing led by M Ventures, Novartis Venture Fund and Omega Funds.

Scipio bioscience announces €6m Series A funding led by M Ventures

– FRANCE, Paris –  Scipio bioscience, a Paris-based biotechnology company, developing a new generation of single-cell sequencing solutions, announces today that it has secured a €6M Series A financing from an international syndicate led by M Ventures, the corporate venture capital arm of Merck.…

Ribometrix announces Hakan Goker to its Board along with raising $30m Series A financing led by M Ventures

– USA, NC – Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, announced today that it has completed a $30 million Series A financing to advance its discovery platform and internal pipeline of novel small molecule drugs that directly modulate RNA activity, as well as expand its team and business development activity.…

Talent4Boards
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.